klinik retatrutide (“reta”) is an experimental weight-loss drug currently in Phase 3 clinical trials. It's a once-weekly injection similar to Ozempic and Mounjaro—but more powerful. The reason comes down to how it works Retatrutide for Weight Loss: TRIUMPH-1

Reconstitution and Administration for Laboratory Use A peptide protocol can look perfect on paper and still fail in execution

(3) This theorized pathway involves the activation of phospholipase C (PLC), which some researchers believe may lead to the increased release of inositol triphosphate (IP3) and diacylglycerol (DAG)

Jan 1987;26(1):151-9

The trade-off is precision: the smaller the microgram per IU, the more forgiving the syringe granularity, but the larger the injection volume per study event

1 DOI: 10.1080/07357907.2025.2585512 Cite This Page : ScienceDaily

Role of smooth muscle cells in the initiation and early progression of atherosclerosis